Evaluación de sustancias - CoRAP

Evaluación de sustancias - CoRAP

Evaluación de sustancias - CoRAP

If a substance is on this list, it means that a Member State has evaluated or will evaluate it over the coming years. The list is called the Community rolling action plan (CoRAP).

For each substance, the table shows the evaluating Member State, the (planned) year of evaluation and a short description of the concern which led to it being placed on the list.

Documents to do with substance evaluation are also available here. They include: documents justifying selection of the substances, decisions to request more information.  Member States' conclusions and Member States' final evaluation reports are included for substances for which evaluation has been finalised.

 

Notes to the Substance Evaluation table
  • Where two Members States are indicated, this is a joint evaluation. The first Member State mentioned leads the Evaluation and is the responsible competent authority in the meaning of Article 45(2) of REACH.
  • The substance public name is used. In most of the cases it is the name as disseminated on the ECHA website.
  • When the EC Number is not available, the number assigned to substance by ECHA after the inquiry process is used.
  • When the substances are included in the CoRAP, they have not yet been evaluated and thus the concern is indicative and not exhaustive or conclusive.
  • Contact details of the evaluating Member States are provided for all the substance included.
  • Please note that the justification document explains the grounds of the initial concerns that triggered the inclusion of the substance in the CoRAP for further clarification under substance evaluation. The justification document is based on a preliminary screening of the substance and is without prejudice to the outcome of the substance evaluation.

Legend:

Suspected PBT/vPvB: Potentially Persistent, Bioaccumulative and Toxic/very Persistent and very Bioaccumulative.
Suspected PMT/vPvM: Potentially Persistent, Mobile and Toxic/very Persistent and very Mobile.
CMR: generic term for known carcinogenic and/or mutagenic and/or reprotoxic properties (according to CLP harmonised or registrant self-classification or CLP Inventory). The concern can refer to C, M, R or a combination of those.
Suspected CMR: generic term for suspected carcinogenic and/or mutagenic and/or reprotoxic properties (not classified according to CLP harmonised or registrant self-classification). The concern can refer to (suspected) C, M, R or a combination of those.
Sensitiser: generic term for known sensitising properties (according to CLP harmonised or registrant self-classification or CLP Inventory).
Suspected sensitiser: generic term for suspected sensitising properties (not classified according to CLP harmonised or registrant self-classification).
RCR: Risk Characterisation Ratio 

Last updated 19 marzo 2024. Database contains 402 unique substances/entries.
Filter the list
Initial grounds for concern:

The List does not contain any Substances.
 
204-279-1
118-82-1
2014
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Wide dispersive use
Follow-up
Details
622-542-2
3891-98-3
Austria
Suspected Mutagenic
Suspected PBT/vPvB
Suspected Sensitiser
Consumer use
Exposure of environment
Exposure of workers
Withdrawn
Details
203-680-9
109-55-7
2014
Austria
Sensitiser
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
202-525-2
96-69-5
2015
Austria
Suspected CMR
Potential endocrine disruptor
Suspected PBT/vPvB
Sensitiser
Consumer use
Wide dispersive use
Information requested
Details
204-820-1
127-06-0
2016
Austria
Suspected Carcinogenic
Suspected Mutagenic
Suspected Sensitiser
Exposure of environment
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
201-247-9
80-07-9
2019
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
212-791-1
870-08-6
2024
Austria
Suspected Reprotoxic
Potential endocrine disruptor
Suspected PBT/vPvB
Consumer use
Exposure of environment
Exposure of workers
High (aggregated) tonnage
High RCR
Wide dispersive use
Ongoing
Details
200-849-9
75-21-8
2012
Austria
CMR
High (aggregated) tonnage
Concluded
Details
249-535-3
29253-36-9
Austria
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Withdrawn
Details
203-571-6
108-31-6
2013
Austria
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
221-374-3
3081-01-4
2012
Austria
Suspected PBT/vPvB
Wide dispersive use
Ongoing
Details
231-890-0
7775-14-6
2016
Austria
Suspected Carcinogenic
Suspected Sensitiser
Consumer use
Exposure of workers
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
203-570-0
108-30-5
2013
Austria
Suspected CMR
Sensitiser
High (aggregated) tonnage
High RCR
Concluded
Details
222-020-0
3319-31-1
2012
Austria
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Ongoing
Details
206-022-9
288-88-0
2015
Belgium
Suspected CMR
Other hazard based concern
Exposure of environment
High (aggregated) tonnage
Other exposure/risk based concern
Wide dispersive use
Concluded
Details
216-475-4
1594-08-7
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
211-989-5
732-26-3
2017
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
202-532-0
96-76-4
2017
Belgium
Suspected CMR
Potential endocrine disruptor
Consumer use
Wide dispersive use
Information requested
Details
226-866-1
5521-31-3
Belgium
Suspected PBT/vPvB
Withdrawn
Details
203-079-1
103-09-3
2015
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Concluded
Details
215-925-7
1453-58-3
2018
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Wide dispersive use
Follow-up
Details
428-970-4
13595-25-0
2014
Belgium
Suspected PBT/vPvB
Other hazard based concern
Consumer use
Exposure of environment
Concluded
Details
201-250-5
80-09-1
2014
Belgium
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
Concluded
Details
D-8; DD-8
405-520-5
95235-30-6
2025
Belgium
Potential endocrine disruptor
Other exposure/risk based concern
Not started
Details
700-403-8
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
-
-
2018
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
253-775-4
38083-17-9
2014
Belgium
Suspected CMR
Consumer use
Wide dispersive use
Conclusion under preparation
Details
203-629-0
108-91-8
2016
Belgium
Reprotoxic
Exposure of environment
High (aggregated) tonnage
Concluded
Details
214-189-4
1112-39-6
Belgium
Reprotoxic
Other hazard based concern
Exposure of workers
Withdrawn
Details
700-427-9
-
2013
Belgium
Suspected PBT/vPvB
Consumer use
Wide dispersive use
Concluded
Details
221-375-9
3081-14-9
2012
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
205-201-9
135-57-9
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Concluded
Details
432-520-2
232938-43-1
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Withdrawn
Details
267-636-0
67905-17-3
2019
Belgium
Suspected PBT/vPvB
Ongoing
Details
206-420-2
338-83-0
2020
Belgium
Suspected PBT/vPvB
Exposure of environment
Follow-up
Details
201-344-6
81-33-4
Belgium
Suspected PBT/vPvB
Withdrawn
Details
202-307-7
94-13-3
2015
Belgium
Suspected Reprotoxic
Potential endocrine disruptor
Consumer use
Exposure of environment
Exposure of sensitive populations
Wide dispersive use
Concluded
Details
473-390-7
-
2016
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
907-745-9
-
2015
Belgium
Suspected PBT/vPvB
High (aggregated) tonnage
Wide dispersive use
Concluded
Details
ROBAC AS/100
403-030-6
137398-54-0
Belgium
Suspected PBT/vPvB
Concluded
Details
X4261
401-850-9
255881-94-8
2014
Belgium
Suspected PBT/vPvB
Exposure of environment
Wide dispersive use
Concluded
Details
203-820-9
110-97-4
2013
Czech Republic
Suspected CMR
Suspected Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
219-470-5
2440-22-4
2016
Czech Republic
Sensitiser
Consumer use
Exposure of workers
High RCR
Wide dispersive use
Concluded
Details
BENZYL-2-NAPHTHYLETHER; BETA-NAPHTHYLBENZYLETHER (BON); BNE; BON; NIPAFAX BNE; SENSLON-50; ZO-1
405-490-3
613-62-7
2012
Czech Republic
Other hazard based concern
High (aggregated) tonnage
Concluded
Details
202-804-9
99-96-7
2014
Czech Republic
Suspected CMR
Potential endocrine disruptor
Consumer use
High (aggregated) tonnage
Concluded
Details
217-175-6
1762-95-4
2015
Czech Republic
Suspected CMR
Potential endocrine disruptor
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
200-901-0
75-78-5
2014
Czech Republic
Suspected PBT/vPvB
High (aggregated) tonnage
Concluded
Details
701-266-7
-
2018
Czech Republic
Sensitiser
Consumer use
High (aggregated) tonnage
High RCR
Wide dispersive use
Concluded
Details
248-607-1
27689-12-9
2024
Denmark
Suspected Reprotoxic
Potential endocrine disruptor
Exposure of environment
Exposure of workers
Wide dispersive use
Ongoing
Details
701-339-3
-
2014
Denmark
Suspected CMR
High (aggregated) tonnage
Other exposure/risk based concern
Concluded
Details

Export search results to: